Search alternatives:
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
841
-
842
Transforming growth factor (TGF)-β1 induced a robust decrease in S-phase in non-cancer cell strains
Published 2011“…Representative histograms are presented illustrating cells that had a robust decrease in S-phase (NMuMG), modest decrease in S-phase (EpH4), and no decrease in S-phase (MDA-MB-436) as a result of TGF-βtreatment. …”
-
843
-
844
-
845
-
846
-
847
-
848
-
849
-
850
-
851
<i>csrnp1a</i> knockdown decreases the number of blood cells in circulation.
Published 2013“…(I) qPCR with primers located in exon 2 and 3 of 24 hpf control embryos (C) and splicing morphants injected with two concentrations, 2,5 and 5 ng per embryo, showing the relative expression of <i>csrnp1a</i> message, which decreases significantly in a dose-dependent manner (t student p<0,01).…”
-
852
-
853
-
854
-
855
-
856
-
857
-
858
IL-35 decreased the prevalence of Th17 in CD4+ T cells.
Published 2017“…<p>(A)The ratio of Th17 in CD4+ T cells. (B) Representative diagram showing Th17’s ratio in CD4+ T cells was significantly decreased in the IL-35 group compared to that in the control group (0.3% vs. 7.2% on day 5, P<0.01). …”
-
859
-
860